logo-large
  • Browse Categories

Publications by authors named "Ladislas Capdevila"

Claim this Profile
I
Imlifidase, a new option to optimize the management of patients with hemophilia A on emicizumab.
Melissa Bou-Jaoudeh, Angelina Mimoun, Sandrine Delignat, Ivan Peyron, Ladislas Capdevila

J Thromb Haemost· October 2023


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emicizumab does not interfere with the activated clotting time.
Ladislas Capdevila, Corinne Frère, Maximilien Desvages, Annie Harroche, Cécile Bally

Haemophilia· March 2022


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reappearance of inhibitor in a tolerized patient with severe haemophilia A during FVIII-free emicizumab therapy.
Ladislas Capdevila, Delphine Borgel, Dominique Lasne, Sebastien Lacroix-Desmazes, Maximilien Desvages

Haemophilia· July 2021


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-sensitivity cardiac troponin-I analytical imprecisions evaluated by internal quality control or imprecision profile.
Mehdi Hage-Sleiman, Ladislas Capdevila, Sophie Bailleul, Guillaume Lefevre

Clin Chem Lab Med· March 2019


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: